ABBVIE INC (ABBV) Fundamental Analysis & Valuation

NYSE:ABBV • US00287Y1091

Current stock price

211.59 USD
+5.22 (+2.53%)
At close:
210.592 USD
-1 (-0.47%)
After Hours:

This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ABBV Profitability Analysis

1.1 Basic Checks

  • In the past year ABBV was profitable.
  • ABBV had a positive operating cash flow in the past year.
  • Each year in the past 5 years ABBV has been profitable.
  • In the past 5 years ABBV always reported a positive cash flow from operatings.
ABBV Yearly Net Income VS EBIT VS OCF VS FCFABBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • ABBV has a better Return On Assets (3.12%) than 89.36% of its industry peers.
  • ABBV's Return On Invested Capital of 14.42% is amongst the best of the industry. ABBV outperforms 95.94% of its industry peers.
  • ABBV had an Average Return On Invested Capital over the past 3 years of 12.12%. This is significantly below the industry average of 27.63%.
  • The last Return On Invested Capital (14.42%) for ABBV is above the 3 year average (12.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ABBV Yearly ROA, ROE, ROICABBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • ABBV has a better Profit Margin (6.84%) than 89.56% of its industry peers.
  • ABBV's Profit Margin has declined in the last couple of years.
  • ABBV's Operating Margin of 34.23% is amongst the best of the industry. ABBV outperforms 96.52% of its industry peers.
  • In the last couple of years the Operating Margin of ABBV has grown nicely.
  • The Gross Margin of ABBV (71.62%) is better than 81.43% of its industry peers.
  • In the last couple of years the Gross Margin of ABBV has remained more or less at the same level.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
ABBV Yearly Profit, Operating, Gross MarginsABBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. ABBV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABBV is still creating some value.
  • Compared to 1 year ago, ABBV has about the same amount of shares outstanding.
  • The number of shares outstanding for ABBV remains at a similar level compared to 5 years ago.
  • ABBV has a worse debt/assets ratio than last year.
ABBV Yearly Shares OutstandingABBV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABBV Yearly Total Debt VS Total AssetsABBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • ABBV has an Altman-Z score of 2.28. This is not the best score and indicates that ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.28, ABBV is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
  • The Debt to FCF ratio of ABBV is 3.79, which is a good value as it means it would take ABBV, 3.79 years of fcf income to pay off all of its debts.
  • ABBV has a Debt to FCF ratio of 3.79. This is amongst the best in the industry. ABBV outperforms 92.07% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.28
ROIC/WACC1.66
WACC8.71%
ABBV Yearly LT Debt VS Equity VS FCFABBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • ABBV has a Current Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of ABBV (0.67) is worse than 89.94% of its industry peers.
  • A Quick Ratio of 0.56 indicates that ABBV may have some problems paying its short term obligations.
  • ABBV has a worse Quick ratio (0.56) than 90.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
ABBV Yearly Current Assets VS Current LiabilitesABBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. ABBV Growth Analysis

3.1 Past

  • The earnings per share for ABBV have decreased by -1.19% in the last year.
  • ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
  • ABBV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.57%.
  • ABBV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.95% yearly.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
  • ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABBV Yearly Revenue VS EstimatesABBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ABBV Yearly EPS VS EstimatesABBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

8

4. ABBV Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.16 indicates a rather expensive valuation of ABBV.
  • Based on the Price/Earnings ratio, ABBV is valued cheaply inside the industry as 93.04% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.91. ABBV is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 14.26, ABBV is valued correctly.
  • Based on the Price/Forward Earnings ratio, ABBV is valued cheaply inside the industry as 96.13% of the companies are valued more expensively.
  • ABBV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.16
Fwd PE 14.26
ABBV Price Earnings VS Forward Price EarningsABBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ABBV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ABBV is cheaper than 94.20% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ABBV is valued cheaper than 95.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21
EV/EBITDA 14.6
ABBV Per share dataABBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ABBV has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%

7

5. ABBV Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.30%, ABBV has a reasonable but not impressive dividend return.
  • ABBV's Dividend Yield is rather good when compared to the industry average which is at 1.11. ABBV pays more dividend than 99.23% of the companies in the same industry.
  • ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.3%

5.2 History

  • On average, the dividend of ABBV grows each year by 6.76%, which is quite nice.
  • ABBV has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ABBV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.76%
Div Incr Years12
Div Non Decr Years12
ABBV Yearly Dividends per shareABBV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 278.48% of the earnings are spent on dividend by ABBV. This is not a sustainable payout ratio.
  • The dividend of ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
ABBV Yearly Income VS Free CF VS DividendABBV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
ABBV Dividend Payout.ABBV Dividend Payout, showing the Payout Ratio.ABBV Dividend Payout.PayoutRetained Earnings

ABBV Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

NYSE:ABBV (4/8/2026, 8:14:54 PM)

After market: 210.592 -1 (-0.47%)

211.59

+5.22 (+2.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners76.17%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner Change6.1%
Market Cap374.13B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target256.47 (21.21%)
Short Float %1.42%
Short Ratio3.42
Dividend
Industry RankSector Rank
Dividend Yield 3.3%
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.31%
PT rev (3m)2.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.62%
EPS NY rev (1m)0%
EPS NY rev (3m)2.1%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
Industry RankSector Rank
PE 21.16
Fwd PE 14.26
P/S 6.12
P/FCF 21
P/OCF 19.66
P/B N/A
P/tB N/A
EV/EBITDA 14.6
EPS(TTM)10
EY4.73%
EPS(NY)14.84
Fwd EY7.01%
FCF(TTM)10.08
FCFY4.76%
OCF(TTM)10.76
OCFY5.09%
SpS34.59
BVpS-1.85
TBVpS-51.78
PEG (NY)0.44
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.28
F-Score8
WACC8.71%
ROIC/WACC1.66
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / ABBV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to ABBV.


What is the valuation status for ABBV stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.


What is the profitability of ABBV stock?

ABBVIE INC (ABBV) has a profitability rating of 7 / 10.


What is the valuation of ABBVIE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 21.16 and the Price/Book (PB) ratio is -114.41.


Is the dividend of ABBVIE INC sustainable?

The dividend rating of ABBVIE INC (ABBV) is 7 / 10 and the dividend payout ratio is 278.48%.